Applications of C-(1-Methyl-Pyrrolidin-3-Yl)-Methylamine in Industrial Manufacturing

As a direct manufacturer of C-(1-Methyl-Pyrrolidin-3-Yl)-Methylamine, we support key industries that rely on high-purity intermediates for advanced synthesis and tightly controlled production environments. Below are detailed, factual scenarios where our material serves as an essential precursor or processing component, with clear focus on industrial specifications, approved usage levels, integration points, and downstream finished products.

1. Pharmaceutical Intermediate Synthesis for CNS Agents

Our material functions as a critical intermediate in the synthesis of several central nervous system (CNS) active pharmaceutical ingredients. The molecular structure provides a pyrrolidine scaffold suitable for producing high-value compounds used in the treatment of neurological and psychiatric disorders. The compound’s defined reactivity ensures predictable output during the active API (active pharmaceutical ingredient) phase, supporting stringent batch records and traceability.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) general monographs for intermediates
• FDA 21 CFR Part 210/211 (US cGMP requirements for finished pharmaceuticals)
• Chinese Pharmacopoeia for registered API synthesis pathways

Typical usage ratio

• 0.15–0.48 molar equivalents, calculated based on targeted batch scale and the required stoichiometry for API precursor formation. Chemists adjust the amount according to specific target yields, impurity profiles, and downstream conversion rates.

Downstream process integration

• We supply our material to the initial condensation or reductive amination step for building CNS-active cores. These steps occur immediately prior to ring closure or N-alkylation, often in jacketed reactors under closed cGMP protocols with in-process QC.

Final product types

• Formulated CNS drugs including antipsychotic tablets, ADHD treatment capsules, and mood stabilizer actives packaged for regulated markets.

2. Synthesis of Agrochemical Active Ingredients

Our product enters the crop protection sector as an intermediate for specialty agrochemical active ingredients that leverage the pyrrolidine backbone. These molecular intermediates support downstream formulation of insecticides, plant growth regulators, and soil treatment agents designed for high stability and selectivity. End-users value the material’s narrow specification control, minimizing unknowns in process validation and environmental monitoring.

Industry compliance standards

• FAO/WHO JMPS Specifications for Crop Protection Products
• EU Regulation (EC) No 1107/2009 for plant protection compounds
• ISO 9001:2015 certified QC for traceability
• Chinese Ministry of Agriculture GB2763 Maximum Residue Limits (relevant to raw materials in synthesis process)

Typical usage ratio

• 0.08–0.25 % w/w relative to the core active structure build; downstream integrators select quantities based on conversion efficiency and residual content allowable, with batch adjustments driven by analytical validation for each target molecule family.

Downstream process integration

• Our material feeds directly into the N-alkylation or cyclization step of technical-grade agrochemical synthesis. Processing engineers typically dose it after pre-mix in continuous batch reactors, maintaining material balances and impurity tracking under ISO-calibrated setups.

Final product types

• Granular and liquid insecticide formulations, microencapsulated seed treatments, and shelf-stable growth regulator solutions distributed to agricultural supply chains.

3. Fine Chemical Production for Specialty Monomers

Manufacturers of advanced polymers and resin additives select this material as a precursor in developing specialty monomers that demand precise amine incorporation. The compound’s stable functional groups are compatible with controlled free-radical or ionic polymerization methods, facilitating downstream development of high-performance resins and surface treatment agents for electronics and engineering plastics.

Industry compliance standards

• ISO 14001:2015 Environmental Management (compliance in fine chemicals sector)
• REACH Regulation (EC) No 1907/2006 for chemical safety registration
• UL 94 (for polymer product safety where downstream use involves electronics applications)
• RoHS Directive 2011/65/EU for allowable levels in final consumer articles

Typical usage ratio

• 0.2–1.0 mole percent in precursor blend, calibrated by final resin crosslinking density and the desired N-functional ratio in the polymer backbone; process optimization studies inform the exact point of addition.

Downstream process integration

• The material integrates during initial monomer batch pre-mix as part of amine-initiated or amine-modified polymer reactions, typically under nitrogen purge in pilot or bulk reactors prior to chain propagation stages.

Final product types

• Specialty adhesives, electronics encapsulants, anti-static polymer additives, and surface-active resin preparations for coatings manufacturers.

4. Building Block for Chiral Catalyst Ligands

In advanced catalysis, our raw material supplies a functional group foundation for the synthesis of chiral ligand systems applied in asymmetric hydrogenation and other enantioselective reactions. Research and process chemistry customers use its unique configuration to anchor chiral centers, which support high-value, catalyst-driven manufacturing for APIs and specialty fine chemicals. Reliable access to well-characterized batches ensures high yields and reproducibility in multi-step ligand preparations.

Industry compliance standards

• USP–NF (United States Pharmacopeia–National Formulary) reference standards for ligand purity
• ISO 17025 for testing and calibration laboratories handling catalyst components
• Regulatory Technical Dossiers for chiral catalyst intermediates (EU and US markets)
• GMP for Investigational Medicinal Products (EU EudraLex Volume 4, Part I)

Typical usage ratio

• 0.10–0.35 equivalents per ligand scaffold, calculated by ligation site availability and the desired chirality induction rate in specific downstream catalyst batch runs.

Downstream process integration

• This amine derivative is introduced as a core amination feedstock during multi-step ligand synthesis, often at the step preceding final metal complexation, in controlled reactors equipped for sensitive chiral synthesis.

Final product types

• Enantioselective catalysts and ligand-metal complexes for the pharmaceutical, agrochemical, and fine chemical sectors, supplied as packaged catalyst kits or bulk complex powders.